Patents by Inventor Céline Lafont

Céline Lafont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8557537
    Abstract: The present invention relates to a method for the production of an overproducing Staphylococcus aureus strain comprising: (a) culturing a Staphylococcus aureus strain on a culture medium M1, M2 or M3, (b) optionally, recovering the strains thus produced from the culture medium, and also to the use of said strains for the production of polysaccharides.
    Type: Grant
    Filed: September 13, 2010
    Date of Patent: October 15, 2013
    Assignee: Sanofi Pasteur SA
    Inventors: Bachra Rokbi, Celine Lafont
  • Patent number: 7863013
    Abstract: The present invention relates to a method for the production of an overproducing Staphylococcus aureus strain comprising: (a) culturing a Staphylococcus aureus strain on a culture medium M1, M2 or M3, (b) optionally, recovering the strains thus produced from the culture medium, and also to the use of said strains for the production of polysaccharides.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: January 4, 2011
    Assignee: Sanofi Pasteur S.A.
    Inventors: Bachra Rokbi, Céline Lafont
  • Publication number: 20100330656
    Abstract: The present invention relates to a method for the production of an overproducing Staphylococcus aureus strain comprising: (a) culturing a Staphylococcus aureus strain on a culture medium M1, M2 or M3, (b) optionally, recovering the strains thus produced from the culture medium, and also to the use of said strains for the production of polysaccharides.
    Type: Application
    Filed: September 13, 2010
    Publication date: December 30, 2010
    Applicant: SANOFI PASTEUR SA
    Inventors: Bachra Rokbi, Céline Lafont
  • Publication number: 20070031939
    Abstract: The present invention relates to a method for the production of an overproducing Staphylococcus aureus strain comprising: (a) culturing a Staphylococcus aureus strain on a culture medium M1, M2 or M3, (b) optionally, recovering the strains thus produced from the culture medium, and also to the use of said strains for the production of polysaccharides.
    Type: Application
    Filed: April 21, 2006
    Publication date: February 8, 2007
    Applicant: Sanofi Pasteur SA
    Inventors: Bachra Rokbi, Celine Lafont